CM
BSX icon

Churchill Management’s Boston Scientific BSX Stock Holding History

Churchill Management’s Portfolio BSX Stock Details BSX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		$21M Sell
195,676
-1,016
-0.5% -$103K 0.23% 37
2025
Q1 		$19.8M Sell
196,692
-559
-0.3% -$56.3K 0.25% 31
2024
Q4 		$17.6M Buy
197,251
+549
+0.3% +$48.3K 0.19% 38
2024
Q3 		$16.5M Buy
196,702
+4,169
+2% +$329K 0.19% 45
2024
Q2 		$14.8M Buy
192,533
+2,211
+1% +$162K 0.17% 49
2024
Q1 		$13M Buy
190,322
+5,343
+3% +$344K 0.16% 50
2023
Q4 		$10.7M Sell
184,979
-1,058
-0.6% -$56.5K 0.16% 50
2023
Q3 		$9.82M Sell
186,037
-169
-0.1% -$8.86K 0.17% 61
2023
Q2 		$10.1M Sell
186,206
-1,703
-0.9% -$88.9K 0.17% 64
2023
Q1 		$9.4M Buy
187,909
+875
+0.5% +$41.2K 0.19% 67
2022
Q4 		$8.65M Buy
187,034
+3,785
+2% +$164K 0.21% 65
2022
Q3 		$7.1M Sell
183,249
-3,075
-2% -$123K 0.19% 68
2022
Q2 		$6.94M Buy
186,324
+1,025
+0.6% +$41.7K 0.17% 73
2022
Q1 		$8.21M Buy
185,299
+25,879
+16% +$1.12M 0.14% 74
2021
Q4 		$6.77M Buy
159,420
+12,026
+8% +$505K 0.09% 106
2021
Q3 		$6.39M Buy
147,394
+8,596
+6% +$380K 0.1% 105
2021
Q2 		$5.93M Buy
+138,798
New +$5.84M 0.09% 116
2017
Q4 		– Sell
-139,118
Closed -$4.06M – 132
2017
Q3 		$4.06M Sell
139,118
-1,515
-1% -$41.8K 0.1% 80
2017
Q2 		$3.9M Sell
140,633
-2,296
-2% -$60.9K 0.1% 77
2017
Q1 		$3.56M Sell
142,929
-14,479
-9% -$352K 0.1% 79
2016
Q4 		$3.4M Sell
157,408
-11,188
-7% -$244K 0.11% 76
2016
Q3 		$4.01M Sell
168,596
-12,730
-7% -$304K 0.16% 68
2016
Q2 		$4.24M Sell
181,326
-10,950
-6% -$237K 0.28% 65
2016
Q1 		$3.62M Sell
192,276
-17,631
-8% -$310K 0.25% 69
2015
Q4 		$3.87M Buy
209,907
+12,633
+6% +$226K 0.18% 76
2015
Q3 		$3.24M Buy
197,274
+12,025
+6% +$206K 0.26% 79
2015
Q2 		$3.28M Buy
185,249
+10,759
+6% +$192K 0.12% 99
2015
Q1 		$3.1M Buy
+174,490
New +$2.76M 0.11% 103

Other funds holding BSX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Churchill Management's BSX Position: Q2 2025 in Review

Churchill Management reduced its Boston Scientific (BSX) stake by 0.52% in Q2 2025, selling an estimated $103K and leaving 195,676 shares worth $21M. The position accounts for 0.23% of the portfolio, ranked #37.

Churchill Management first reported a position in BSX in Q1 2015 and has held it in 28 quarters since. 1,687 funds tracked by Wall St. Rank hold BSX as of Q2 2025.

  • Churchill Management held 195,676 shares of Boston Scientific worth $21M as of Q2 2025.
  • Churchill Management sold 1,016 Boston Scientific shares in Q2 2025, an estimated $103K.
  • Boston Scientific made up 0.23% of Churchill Management's portfolio in Q2 2025, its #37 holding.
  • Churchill Management first reported a position in Boston Scientific in Q1 2015 and has held it in 28 quarters since.
  • 1,687 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2025.

Based on Churchill Management's 13F filing for Q2 2025, filed 18 Jul 2025.